5-methoxytryptamine has been researched along with Dyskinesia Syndromes in 2 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinze, WJ | 1 |
| Schlemmer, RF | 1 |
| Williams, EA | 1 |
| Davis, JM | 1 |
| Messiha, FS | 1 |
2 other studies available for 5-methoxytryptamine and Dyskinesia Syndromes
| Article | Year |
|---|---|
The acute and chronic effect of 5-methoxytryptamine on selected members of a primate social colony.
Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Fe | 1980 |
A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
Topics: 5-Methoxytryptamine; Animals; Biogenic Amines; Chlorpromazine; Dopamine; Epinephrine; Female; Haplor | 1974 |